CN111011861A - A weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and its preparation method - Google Patents
A weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and its preparation method Download PDFInfo
- Publication number
- CN111011861A CN111011861A CN201911364498.9A CN201911364498A CN111011861A CN 111011861 A CN111011861 A CN 111011861A CN 201911364498 A CN201911364498 A CN 201911364498A CN 111011861 A CN111011861 A CN 111011861A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- essence
- conjugated linoleic
- linoleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 title claims abstract description 25
- 229940108924 conjugated linoleic acid Drugs 0.000 title claims abstract description 25
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 title claims abstract description 25
- 235000013361 beverage Nutrition 0.000 title claims abstract description 17
- 230000001603 reducing effect Effects 0.000 title abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 36
- 229940094952 green tea extract Drugs 0.000 claims abstract description 28
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 28
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims abstract description 23
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000839 emulsion Substances 0.000 claims abstract description 22
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000000686 essence Substances 0.000 claims description 43
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 235000011399 aloe vera Nutrition 0.000 claims description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 9
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 8
- 241001116389 Aloe Species 0.000 claims description 8
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 8
- 240000009088 Fragaria x ananassa Species 0.000 claims description 8
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 8
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000001630 malic acid Substances 0.000 claims description 8
- 235000011090 malic acid Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 239000007908 nanoemulsion Substances 0.000 claims description 7
- 239000004386 Erythritol Substances 0.000 claims description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 235000019414 erythritol Nutrition 0.000 claims description 6
- 229940009714 erythritol Drugs 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical group OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- 235000005979 Citrus limon Nutrition 0.000 claims description 5
- 244000131522 Citrus pyriformis Species 0.000 claims description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 235000013618 yogurt Nutrition 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 238000010008 shearing Methods 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 244000144927 Aloe barbadensis Species 0.000 claims description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000005911 diet Nutrition 0.000 claims 5
- 230000037213 diet Effects 0.000 claims 5
- 238000004090 dissolution Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 235000019197 fats Nutrition 0.000 abstract description 17
- 230000008569 process Effects 0.000 abstract description 4
- 238000004260 weight control Methods 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 55
- 239000000047 product Substances 0.000 description 33
- 238000002474 experimental method Methods 0.000 description 25
- 210000000577 adipose tissue Anatomy 0.000 description 19
- 230000002829 reductive effect Effects 0.000 description 15
- 208000016261 weight loss Diseases 0.000 description 15
- 238000003756 stirring Methods 0.000 description 14
- 230000037396 body weight Effects 0.000 description 10
- 210000001789 adipocyte Anatomy 0.000 description 9
- 239000013585 weight reducing agent Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 235000021590 normal diet Nutrition 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 206010067482 No adverse event Diseases 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000011748 cell maturation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000006864 oxidative decomposition reaction Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000006378 Catechol O-methyltransferase Human genes 0.000 description 2
- 108020002739 Catechol O-methyltransferase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000020997 lean meat Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 102000015005 beta-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006818 beta-adrenergic receptor activity proteins Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a weight-reducing product, in particular to a weight-reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and a preparation method thereof. The active ingredients of the beverage are two or more of conjugated linoleic acid glyceride emulsion, L-carnitine and green tea extract; wherein, the weight portion is: 0-60 parts of conjugated linoleic acid glyceride emulsion, 0-10 parts of L-carnitine and 0-2 parts of green tea extract (calculated by EGCG). The weight-reducing product of the invention adopts specific nutrients, specific proportion and process to obtain the CLA-TG containing weight control product. The product achieves scientific and effective effects of reducing fat and losing weight by the cooperation of CLA-TG, L-carnitine and EGCG in green tea extract, thereby achieving the effect of controlling weight.
Description
Technical Field
The invention relates to a weight-reducing product, in particular to a weight-reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and a preparation method thereof.
Background
With the progress of society, people pay more and more attention to the health of the body. Obesity is one of the causes of diabetes, cardiovascular diseases, and other human diseases. It is therefore the best marketed product with the greatest demand.
The conjugated linoleic acid glyceride as a newly discovered nutrient almost becomes the Wanlingdan for preventing modern civilization diseases in European and American health food at present, and is almost indispensable health food for modern people living in twenty-first century from cancer resistance to cardiovascular diseases and diabetes prevention to weight control. Conjugated linoleic acid glyceride (CLA-TG) has the functions of scavenging free radicals, enhancing the oxidation resistance and the immunity of human bodies, promoting growth and development, regulating the levels of blood cholesterol and triglyceride, preventing atherosclerosis, promoting fat oxidative decomposition, promoting protein synthesis of human bodies, carrying out comprehensive benign regulation on human bodies and the like. Recently, more and more clinical research reports prove that CLA-TG has excellent performance in weight control, because general people only focus on reducing weight rather than fat, that is, the body fat ratio is not necessarily changed, and if the people who lose weight can be matched with CLA-TG to use, the ratio of fat tissue to lean tissue in the body can be effectively reduced, so that fat is really reduced to fat, and the lean meat ratio is increased, so that the advantage that the more lean meat, the higher the metabolism capability in the body is, so that a benign cycle is formed, and the weight loss can be more easily achieved. In addition, clinically, the CLA-TG-containing weight loss patients have high emotional stability, can keep a constant weight loss plan, and have good sleeping and mental conditions, and research reports indicate that CLA-TG can prevent yoyo symptoms from occurring in weight loss and avoid the weight loss and obesity and the malignant cycle of obesity and obesity. At present, conjugated linoleic acid glyceride is added into partial weight-losing food, and the food is a natural weight-losing product.
L-carnitine is a key substance in the fat metabolism process and can promote fatty acid to enter mitochondria for oxidative decomposition. Carnitine can be said to be a carrier for transporting fatty acids. In long-term heavy exercise, carnitine increases the rate of oxidation of fat, reduces glycogen consumption, and also delays fatigue. The L-carnitine can reduce body fat and weight without reducing water and muscle, and is considered as the most safe weight-reducing nutritional supplement without side effect by the international obesity health organization in 2003.
However, in the current market, various monomer weight-losing products have more defects, for example, the CLA-TG product used alone has slow effect and long taking period, and a large amount of CLA-TG product can cause reactions such as nausea, vomiting and the like. The action mechanism of the L-carnitine determines that the L-carnitine can not be eaten excessively, the basic metabolism of a human body can be disordered by eating a high-dose L-carnitine product for a long time, abnormal states such as excitation abnormality, tachycardia, insomnia and the like are caused, and the fat reducing effect is not obvious by the low-dose L-carnitine, so that a safe and effective product needs to be obtained.
Disclosure of Invention
The invention aims to provide a weight-reducing drink containing conjugated linoleic acid glyceride (CLA-TG) and a preparation method thereof.
In order to achieve the purpose, the invention adopts the technical scheme that:
a weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) contains two or more of conjugated linoleic acid glyceride emulsion, L-carnitine, and green tea extract as active ingredients; wherein, the weight portion is: 0-60 parts of conjugated linoleic acid glyceride emulsion, 0-10 parts of L-carnitine and 0-2 parts of green tea extract (calculated by EGCG).
The active ingredients of the beverage are conjugated linoleic acid glyceride emulsion, L-carnitine and green tea extract; wherein, the weight portion is: 20-60 parts of conjugated linoleic acid glyceride emulsion, 2-8 parts of L-carnitine and 0-2 parts of green tea extract (calculated by EGCG).
The conjugated linoleic acid glyceride emulsion is nano emulsion obtained by mixing conjugated linoleic acid glyceride with a water phase and an oil phase, shearing, emulsifying and homogenizing.
The green tea extract is prepared from green tea prepared from bud, leaf and stem of tea tree by extracting with water, filtering, concentrating, and drying, wherein the content of EGCG is about 50-98%.
The weight-reducing beverage comprises, by weight, 5-80 parts of active ingredients, 1-10 parts of aloe vera gel, 1-40 parts of carbohydrate and 1-20 parts of flavoring agents.
The carbohydrate is erythritol, xylitol and fructo-oligosaccharide; the weight portions of (1-10): (1-10): (5-20);
the flavoring agent is one or more of sour agent, sweetener, essence and perfume.
The sour agent is one or more of citric acid, malic acid, sorbic acid and lactic acid;
the sweetener bag is one or more of sucralose, stevioside and aspartame;
the essence perfume is one or more of milk essence, orange essence, yogurt essence, cranberry essence, strawberry essence, blueberry essence, lemon essence, etc.
A method for preparing weight-reducing beverage comprises dissolving CLA-TG emulsion in water of 40-60 deg.C at 100-.
The high-temperature sterilization is performed for 15min at the temperature of 90 ℃.
The invention has the advantages that:
the weight-reducing product of the invention adopts specific nutrients, specific proportion and process to obtain the CLA-TG containing weight control product. The product achieves scientific and effective effects of reducing fat and losing weight by the cooperation of CLA-TG, L-carnitine and EGCG in green tea extract, thereby achieving the effect of controlling weight.
The ingredients in the product have different levels of weight-losing effects, but the raw materials are mixed according to a specific proportion, so that the L-carnitine can promote the activity of related enzyme of fatty acid β -oxidation, the EGCG in the green tea extract can reduce fat accumulation, the EGCG and the L-carnitine can further promote the effects of reducing fat and losing weight, meanwhile, the CLA-TG and the EGCG in the green tea extract can obviously reduce the body weight of a subject before and after an experiment, high fat induced body weight increase is effectively reduced, the combination of the EGCG and the L-carnitine in the green tea extract can synergistically promote the weight reduction effect of exercise, the EGCG in the green tea extract can inhibit the activity of catechol-O-methyltransferase, so that the stimulation effect of norepinephrine on a β -adrenergic receptor system is enhanced, energy consumption and fat oxidative decomposition are promoted, in addition, the EGCG in the green tea extract can obviously inhibit the lipid accumulation in 3T3-L1 differentiated fat cells, the pre-cell maturation to mature fat cells can be inhibited, and the number and the volume of the mature fat cells can be effectively reduced.
In conclusion, the product of the invention is superior to common weight-losing and fat-reducing products in the market, has definite edible effect and good market prospect.
Detailed Description
The following examples are presented to further illustrate embodiments of the present invention, and it should be understood that the embodiments described herein are for purposes of illustration and explanation only and are not intended to limit the invention.
The CLA-TG emulsions described in the following examples are all nanoemulsion preparations prepared by mixing CLA-TG with water phase and oil phase, shearing, emulsifying, homogenizing and the like. [ see the literature described in application No. 201910642403.9 for details ]
Namely: (1) completely dissolving 1-25 parts of starch, 1-20 parts of micromolecular filler (DE <40) and 0.01-1 part of preservative in water;
(2) 0.1-3 parts of water phase antioxidant is added into the solution in the step (1), and the mixture is stirred at 40-80 ℃ until the water phase is completely dissolved to obtain a water phase;
(3) completely dissolving 0.1-2 parts of oil-phase antioxidant in 20 parts of conjugated linoleic acid glyceride to prepare an oil phase;
(4) adding the oil phase into the water phase, rapidly heating to 70-90 ℃, and shearing at 3000-8000 rpm for 3-10 minutes; then, the temperature is reduced to 30-40 ℃ in a gradient manner at the speed of 1-3 ℃/min, and then the emulsion is prepared by homogenizing under the pressure of 20-80 MPa.
Example 1
The weight-reducing product is prepared from the following raw materials in parts by weight: 40 parts of CLA-TG emulsion, 4 parts of L-carnitine, 1 part of green tea extract (calculated by EGCG), 10 parts of erythritol, 10 parts of xylitol, 20 parts of fructo-oligosaccharide, 2 parts of aloe gel, 2 parts of citric acid, 2 parts of malic acid, 4 parts of lactic acid, 2 parts of milk essence and 1 part of grape essence.
The preparation method comprises the following steps:
(1) preparing CLA-TG nano emulsion step by step, and then placing the nano emulsion in a water bath kettle at 50 ℃ for heat preservation;
(2) adding a proper amount of water, and stirring at a constant speed of 200rpm until the mixture is completely dispersed into the water;
(3) adding xylitol, fructo-oligosaccharide and aloe gel at the above ratio, respectively, and stirring at 50 deg.C to dissolve completely;
(4) adding L-carnitine and green tea extract (calculated as EGCG) at the above ratio, respectively, and stirring to dissolve completely;
(5) mixing lactic acid, citric acid and malic acid according to the ratio of 2: 1: dissolving the acid aqueous solution of the 1 proportion in water of the same quantity, slowly adding the acid aqueous solution into the emulsion of the 4 proportion, and stirring at a constant speed of 200 rpm;
(6) adding the milk essence and the grape essence into the solution according to the proportion, and stirring at the rotating speed of 200rpm until the milk essence and the grape essence are completely dissolved;
(7) and (3) sterilizing the prepared solution (6) at the temperature of 90 ℃ for 15min, cooling to 80 ℃, filling and sealing to obtain the product.
The products obtained in the above examples were evaluated:
all the subjects in the experiment are subjected to body mass index assessment before the experiment, and the results belong to obese people (BMI is more than 32), wherein 30 men and 30 women in the subjects; the age is 18-55 years, and the average age is 36.5 years. The test population underwent 3 times per week, 45min each time, of low intensity aerobic exercise during the test period. The control group took only water except for the normal diet, and the test group took the product of this example 2 times a day except for the normal diet. The body weight and percent body fat changes were calculated by the T test method (see tables 1 and 2).
TABLE 1 weight changes of subjects before and after the experiment
Period of time | Before test (kg) | 30 days (kg) | 60 days (kg) | 90 days (kg) | Rate of decrease (%) |
Control group of 20 persons | 78.79±6.41 | 78.86±5.74 | 76.92±6.53 | 77.13±6.19 | 2.1±4.73 |
Male test group 20 persons | 85.63±4.33 | 82.13±2.58 | 77.39±5.61 | 73.44±4.82* | 14.24±2.57 |
Female test group 20 persons | 74.32±8.62 | 70.91±8.67 | 67.55±5.76 | 62.21±5.11* | 16.29±7.55 |
As can be seen from Table 1, the body weights of the male test group, the female test group and the control group after the test are all reduced compared with those before the test, and the body weight reduction of the test group before and after the test is significantly different (P is less than 0.05).
TABLE 2 percent change in body fat of subjects before and after the experiment
Period of time | Before test (%) | 30 days (%) | 60 days (%) | 90 days (%) | Rate of decrease (%) |
Control group of 20 persons | 31.71±3.44 | 31.55±5.62 | 30.84±4.38 | 30.65±3.38 | 3.34±2.54 |
Male test group 20 persons | 35.37±5.72 | 31.49±6.76 | 26.77±5.07 | 24.84±3.64* | 29.77±6.81 |
Female test group 20 persons | 38.91±5.49 | 33.44±7.63 | 29.39±4.88 | 26.21±4.41* | 32.64±5.63 |
As can be seen from Table 2, there was no significant difference in the percentage of body fat after the control group experiment compared to before the experiment (P > 0.05). The percent reduction of body fat before and after the experiment of the test group has significant difference (P is less than 0.05).
As can be seen from the above experimental effects, no adverse reaction occurred in the period of taking the fat-reducing product of this example by the subject; in the test, compared with the control group, the test group has a weight reduction amplitude obviously superior to that of the control group, and the weight reduction rates are respectively 2.1 +/-4.73, 14.24 +/-2.57 and 16.29 +/-7.55. The percentage of body fat is remarkably reduced, the reduction rate is 3.34 +/-2.54, 29.77 +/-6.81 and 32.64 +/-5.63, and the results show that the weight of a subject can be quickly reduced and the fat can be quickly reduced when the subject takes the product of the invention to perform certain low-intensity aerobic exercises.
Example 2
The weight-reducing product is prepared from the following raw materials in parts by weight: 50 parts of CLA-TG emulsion, 6 parts of L-carnitine, 20 parts of xylitol, 15 parts of fructo-oligosaccharide, 5 parts of aloe gel, 4 parts of citric acid, 2 parts of malic acid, 2 parts of cranberry essence, 1 part of strawberry essence and 1 part of lemon essence.
The preparation method comprises the following steps:
(1) preparing CLA-TG nano emulsion step by step, and then placing the nano emulsion in a water bath kettle at 50 ℃ for heat preservation;
(2) adding a proper amount of water, and stirring at a constant speed of 200rpm until the mixture is completely dispersed into the water;
(3) adding xylitol, fructo-oligosaccharide and aloe gel at the above ratio, respectively, and stirring at 50 deg.C to dissolve completely;
(4) adding L-carnitine according to the proportion, and stirring until the L-carnitine is completely dissolved;
(5) mixing citric acid and malic acid according to the ratio of 2: dissolving the mixture of 1 in water of the same amount, adding the acidic aqueous solution slowly into the emulsion according to the proportion, and stirring at a constant speed of 200 rpm;
(6) adding the cranberry essence, the strawberry essence and the lemon essence into the solution according to the proportion, and stirring at the rotating speed of 200rpm until the cranberry essence, the strawberry essence and the lemon essence are completely dissolved;
(7) and (3) sterilizing the prepared solution (6) at the temperature of 90 ℃ for 15min, cooling to 80 ℃, filling and sealing to obtain the product.
The products obtained in the above examples were evaluated:
all the subjects in the experiment are subjected to body mass index assessment before the experiment, and the results belong to obese people (BMI is more than 32), wherein 30 men and 30 women in the subjects; the age is 18-55 years, and the average age is 34.1 years. During the test period, the test population underwent low-intensity aerobic exercise for 45min 3 times a week, the control group took only water except for normal diet, and the test group took the product of this example 2 times a day except for normal diet. The body weight and percent body fat changes were calculated by the T test method (see tables 3 and 4).
TABLE 3 weight changes of subjects before and after the experiment
Period of time | Before test (kg) | 30 days (kg) | 60 days (kg) | 90 days (kg) | Rate of decrease (%) |
Control group of 20 persons | 81.51±4.66 | 82.09±3.84 | 81.98±4.62 | 82.24±5.62 | 0 |
Male test group 20 persons | 87.35±4.37 | 85.46±5.99 | 84.42±5.37 | 81.82±3.16* | 6.33±3.59 |
Female test group 20 persons | 79.56±5.69 | 75.45±6.82 | 72.22±6.81 | 71.19±3.84* | 10.52±4.11 |
As can be seen from Table 3, the body weight of the male test group, the female test group and the control group is reduced after the test compared with that before the test, and the body weight reduction of the test group is significantly different (P is less than 0.05) before and after the test.
TABLE 4 percent change in body fat of subjects before and after experiment
Period of time | Before test (%) | 30 days (%) | 60 days (%) | 90 days (%) | Rate of decrease (%) |
Control group of 20 persons | 32.15±3.82 | 32.04±4.28 | 31.84±4.66 | 32.59±2.71 | 0 |
Male test group 20 persons | 35.11±5.72 | 34.18±6.76 | 32.47±4.53 | 31.16±6.62* | 11.25±4.63 |
Female test group 20 persons | 38.25±2.88 | 37.84±3.25 | 35.71±3.52 | 34.73±3.06* | 9.20±5.48 |
As can be seen from Table 4, there was no significant difference in the percentage of body fat after the control group experiment compared to before the experiment (P > 0.05). The percent reduction of body fat before and after the experiment of the test group has significant difference (P is less than 0.05).
As can be seen from the above experimental effects, the weight and body fat changes of two male subjects during the period of taking the product of the present embodiment are not significantly different from those before the test (P > 0.05), and no adverse reaction occurs during the period of taking all the subjects. In the test, compared with the control group, the weight reduction amplitude of the test group is obviously better than that of the control group, and the weight reduction rate is respectively 0%, 6.33 +/-3.59% and 10.52 +/-4.11%. The percentage of body fat is remarkably reduced, the reduction rate is 0%, 11.25 +/-4.63% and 9.20 +/-5.48%, which shows that the subjects can achieve certain weight-reducing and fat-reducing effects by carrying out certain low-intensity aerobic exercises when taking the product of the embodiment.
Example 3
The weight-reducing product is prepared from the following raw materials in parts by weight: 1 part of green tea extract (calculated by EGCG), 10 parts of L-carnitine, 20 parts of erythritol, 10 parts of fructo-oligosaccharide, 4 parts of aloe gel, 4 parts of citric acid, 2 parts of malic acid, 3 parts of orange essence, 1 part of strawberry essence and 1 part of yoghourt essence.
The preparation method comprises the following steps:
(1) respectively adding erythritol, fructo-oligosaccharide and aloe gel according to the proportion, and stirring at a constant speed of 200rpm at 50 ℃ until the erythritol, the fructo-oligosaccharide and the aloe gel are completely dissolved;
(2) adding green tea extract and L-carnitine according to the above proportion, respectively, and stirring to dissolve completely;
(3) mixing citric acid and malic acid according to the ratio of 2: dissolving the mixture of 1 in water of the same amount, adding the acidic aqueous solution slowly into the emulsion according to the proportion, and stirring at a constant speed of 200 rpm;
(4) adding the orange essence, the strawberry essence and the yoghourt essence into the solution according to the proportion, and stirring at the rotating speed of 200rpm until the orange essence, the strawberry essence and the yoghourt essence are completely dissolved;
(5) sterilizing the prepared solution (4) at 90 ℃ for 15min, cooling to 80 ℃, filling and sealing to obtain the product.
The products obtained in the above examples were evaluated:
all the subjects in the experiment are subjected to body mass index assessment before the experiment, and the results belong to obese people (BMI is more than 32), wherein 30 men and 30 women in the subjects; the age is 18-55 years, and the average age is 34.5 years. During the test period, the test population underwent low-intensity aerobic exercise for 45min 3 times a week, the control group took only water except for normal diet, and the test group took the product of this example 2 times a day except for normal diet. The body weight and percent body fat changes were calculated by the T test method (see tables 5 and 6).
TABLE 5 weight changes of subjects before and after the experiment
Period of time | Before test (kg) | 30 days (kg) | 60 days (kg) | 90 days (kg) | Rate of decrease (%) |
Control group of 20 persons | 81.51±4.66 | 81.12±3.74 | 81.88±3.59 | 81.06±4.84 | 0.55±1.16 |
Male test group 20 persons | 91.82±3.47 | 87.19±4.94 | 86.37±5.76 | 84.94±5.62* | 7.49±4.22 |
Female test group 20 persons | 83.55±5.19 | 80.09±4.99 | 76.51±6.43 | 74.35±4.62* | 11.01±4.86 |
As can be seen from Table 5, the body weights of the male test group, the female test group and the control group after the test were all reduced compared with those before the test, and the weight loss of the test group before and after the test was significantly different (P < 0.05).
TABLE 6 percent change in body fat of subjects before and after the experiment
Period of time | Before test (%) | 30 days (%) | 60 days (%) | 90 days (%) | Rate of decrease (%) |
Control group of 20 persons | 32.87±3.73 | 32.04±4.28 | 31.84±4.66 | 32.59±2.71 | 0.85±1.39 |
Male test group 20 persons | 35.39±4.95 | 33.94±3.39 | 32.07±4.91 | 30.43±4.35* | 14.01±3.52 |
Female test group 20 persons | 36.95±3.53 | 35.78±5.05 | 33.54±4.47 | 32.91±3.16* | 10.93±3.18 |
As can be seen from Table 6, there was no significant difference in the percentage of body fat after the control group experiment compared to before the experiment (P > 0.05). The percent reduction of body fat before and after the experiment of the test group has significant difference (P is less than 0.05).
As can be seen from the above experimental effects, the weight and body fat changes of only one male subject during the experiment period of taking the product of the present embodiment have no significant difference (P > 0.05) from those before the experiment, and no adverse reaction occurs during the period of taking all the subjects. In the test, compared with the control group, the weight reduction amplitude of the test group is obviously better than that of the control group, and the weight reduction rate is respectively 0.55 +/-1.16%, 7.49 +/-4.22% and 11.01 +/-4.86%. The percentage of body fat is remarkably reduced, the reduction rate is 0.85 plus or minus 1.39%, 14.01 plus or minus 3.52% and 10.93 plus or minus 3.18%, which indicates that the subjects can achieve certain weight-losing and fat-reducing effects by carrying out certain low-intensity aerobic exercises when taking the product.
The above examples show that the raw materials in the weight-reducing product are two or more of CLA-TG emulsion, L-carnitine and EGCG in green tea extract, the obtained composition has a certain weight-reducing effect after use, wherein when the combination mode is three combinations of CLA-TG, L-carnitine and EGCG in green tea extract, the weight-reducing effect is more obvious than the effect of any two combinations, the experimental result proves that when the three components are mixed according to a specific proportion, the L-carnitine can promote the activity of β -oxidation, the EGCG can reduce fat accumulation, the two components have promoting effects in reducing fat and reducing weight, the EGCG in green tea extract and the L-carnitine combine to obviously reduce the weight of a subject before and after an experiment, simultaneously the weight increase induced by high fat is effectively reduced, the combination of the EGCG and the L-carnitine in green tea extract can synergistically promote the weight reducing effect of exercise, the EGCG can inhibit the activity of catechol-O-methyltransferase, thereby enhancing the stimulation effect of norepinephrine on β -adrenoceptor system, promoting the energy consumption and the decomposition of fat cells in green tea extract, and further obviously inhibiting the decomposition of fat cells in a fat cell maturation process, and the fat cell accumulation is more obviously reduced in weight-reducing effect of the obtained by compounding of CLA-3 and fat cell maturation process of the fat cell growth.
Claims (8)
1. A weight-reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) is characterized in that: the active ingredients of the beverage are two or more of conjugated linoleic acid glyceride emulsion, L-carnitine and green tea extract; wherein, the weight portion is: 0-60 parts of conjugated linoleic acid glyceride emulsion, 0-10 parts of L-carnitine and 0-2 parts of green tea extract (calculated by EGCG).
2. The diet beverage according to claim 1, wherein: the active ingredients of the beverage are conjugated linoleic acid glyceride emulsion, L-carnitine and green tea extract; wherein, the weight portion is: 20-60 parts of conjugated linoleic acid glyceride emulsion, 2-8 parts of L-carnitine and 0-2 parts of green tea extract (calculated by EGCG).
3. A diet drink according to claim 1 or 2, characterized in that: the conjugated linoleic acid glyceride emulsion is nano emulsion obtained by mixing conjugated linoleic acid glyceride with a water phase and an oil phase, shearing, emulsifying and homogenizing.
4. The diet drink according to claims 1 and 2, characterized in that: the weight-reducing beverage comprises, by weight, 5-80 parts of active ingredients, 1-10 parts of aloe vera gel, 1-40 parts of carbohydrate and 1-20 parts of flavoring agents.
5. The diet beverage according to claim 4, wherein: the carbohydrate is erythritol, xylitol and fructo-oligosaccharide; the weight portions of (1-10): (1-10): (5-20);
the flavoring agent is one or more of sour agent, sweetener, essence and perfume.
6. The diet beverage according to claim 4, wherein:
the sour agent is one or more of citric acid, malic acid, sorbic acid and lactic acid;
the sweetener bag is one or more of sucralose, stevioside and aspartame;
the essence perfume is one or more of milk essence, orange essence, yogurt essence, cranberry essence, strawberry essence, blueberry essence, lemon essence, etc.
7. A method for preparing the weight-reducing beverage of claim 1, which is characterized in that: according to the proportion, the CLA-TG emulsion is dissolved in water with the temperature of 40-60 ℃, the mixture is stirred and mixed evenly at the rotating speed of 100-400rpm, then aloe gel, carbohydrate, sour agent, sweetener, L-carnitine, green tea extract and essence perfume are sequentially added, and the product is obtained after complete dissolution and high-temperature sterilization.
8. The method of claim 7, wherein: the high-temperature sterilization is performed for 15min at the temperature of 90 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911364498.9A CN111011861A (en) | 2019-12-26 | 2019-12-26 | A weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911364498.9A CN111011861A (en) | 2019-12-26 | 2019-12-26 | A weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111011861A true CN111011861A (en) | 2020-04-17 |
Family
ID=70214544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911364498.9A Pending CN111011861A (en) | 2019-12-26 | 2019-12-26 | A weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111011861A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113854559A (en) * | 2021-09-23 | 2021-12-31 | 营养屋(成都)生物医药有限公司 | Weight-losing health food and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2422339A1 (en) * | 2003-03-17 | 2004-09-17 | Ehn Inc. | A composition to promote weight loss |
CN101199299A (en) * | 2007-11-09 | 2008-06-18 | 湖南光大牧业科技有限公司 | Lactobacillus milk beverage containing conjugated linoleic acid and preparation method thereof |
CN101238881A (en) * | 2007-02-08 | 2008-08-13 | 内蒙古新鸿盛高科技园区有限责任公司 | Conjugated linoleic acid type lipid-lowering and fat-reducing multifunctional food |
CN102018832A (en) * | 2010-11-16 | 2011-04-20 | 北京康比特体育科技股份有限公司 | Weight-reducing composition and preparation method thereof |
-
2019
- 2019-12-26 CN CN201911364498.9A patent/CN111011861A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2422339A1 (en) * | 2003-03-17 | 2004-09-17 | Ehn Inc. | A composition to promote weight loss |
CN101238881A (en) * | 2007-02-08 | 2008-08-13 | 内蒙古新鸿盛高科技园区有限责任公司 | Conjugated linoleic acid type lipid-lowering and fat-reducing multifunctional food |
CN101199299A (en) * | 2007-11-09 | 2008-06-18 | 湖南光大牧业科技有限公司 | Lactobacillus milk beverage containing conjugated linoleic acid and preparation method thereof |
CN102018832A (en) * | 2010-11-16 | 2011-04-20 | 北京康比特体育科技股份有限公司 | Weight-reducing composition and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
杨金香等: "《医用化学》", 31 December 2009, 人民军医出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113854559A (en) * | 2021-09-23 | 2021-12-31 | 营养屋(成都)生物医药有限公司 | Weight-losing health food and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100539877C (en) | Alcohol-dissolving liver-protecting drink and preparation method thereof | |
CN101642165B (en) | Method for preparing weight-reducing yoghurt beverage | |
CN106306639B (en) | Lactic acid bacteria collagen jelly and its manufacturing method | |
JP4231208B2 (en) | Nutritional supplements derived from fermented milk for the prevention of osteoporosis | |
KR20140103572A (en) | A functional liquid composition comprising arginine, maca powder extract, citric acid and polydextrose as main ingredients | |
CN108782874A (en) | A kind of selenium-rich black tea drinks | |
CN101496607B (en) | Barley seedling and buckwheat seedling composite fresh-keeping beverage and preparation method thereof | |
CN110279048A (en) | A kind of composite fruit juice function factor beverage and preparation method thereof | |
CN111011861A (en) | A weight reducing beverage containing conjugated linoleic acid glyceride (CLA-TG) and its preparation method | |
KR101348311B1 (en) | Fermented extract of garlic and manufacturing process of the same | |
CN107446790A (en) | A kind of fruit vinegar health-preserving beverage and preparation method thereof | |
CN1823604B (en) | Seaweed tea and its preparation method | |
CN108186883A (en) | A kind of Traditional Chinese medicine composition for tonifying qi and nourishing blood and preparation method thereof | |
CN105602796B (en) | A kind of Chinese anise wine and preparation method thereof | |
KR100364000B1 (en) | Sports beverage composition and method thereof | |
KR20100020862A (en) | Method of preparing fermented liquid of garlic and chonggugjang | |
CN103976211B (en) | Jelly of a kind of fat-reducing and preparation method thereof | |
CN107156841B (en) | Acanthopanax sessiliflorus extract, application of acanthopanax sessiliflorus extract, acanthopanax sessiliflorus beverage and preparation method thereof | |
RU2396033C1 (en) | Soft drink | |
JP4524465B2 (en) | Antiallergic agent | |
JP4141271B2 (en) | Citrus extract composition | |
CN106689370A (en) | Method for preparing fruity yoghourt | |
CN106418509A (en) | Immunity-enhancing ginseng polysaccharide oral liquid and preparation method thereof | |
CN113749203A (en) | Beverage with weight reducing effect and preparation method thereof | |
CN105950335A (en) | Quinoa rice wine and dioscorea opposita thunb juice and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200417 |
|
RJ01 | Rejection of invention patent application after publication |